Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT02614963 Not yet recruiting - Clinical trials for Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome

Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome

Start date: December 2015
Phase: Phase 4
Study type: Interventional

Clostridium Butyricum might be an effective drug in treating irritable bowel syndrome

NCT ID: NCT02611193 Not yet recruiting - Clinical trials for Carpal Tunnel Syndrome

Efficacy of Manipulative Treatment for Carpal Tunnel Syndrome

Start date: May 2016
Phase: N/A
Study type: Interventional

Hypothesis: Manipulative treatment can relieve patients of discomfort and dysfunction and then be utilized as a cheap conservative management of CTS. Study design: Two-groups randomized single-blind interventional study.

NCT ID: NCT02606812 Not yet recruiting - Clinical trials for Metabolic Syndrome X

Effect of Food Consumption on microRNA Related to Metabolic Syndrome

EFCMRNAMS
Start date: March 2017
Phase: N/A
Study type: Interventional

The objective of the Project is to assess the effect of traditional food on the expression of micro-ribonucleic acid (miRNA), which regulate genes related to glucose metabolism. It will be a randomized experimental research. The research hypothesis is that consumption of traditional food will resolve biomarkers of glucose-related anomalies. Students of The Academic Division of Health Sciences (DACS for its initials in Spanish) will be invited to participate and they will be divided randomly in two groups. The experimental group will receive daily, five days per week, during three months, a lunch based on traditional Mesoamerican food emphasizing local produce. The experimental group will be provided an equivalent ratio of fast food from the school cafeterias. In both groups, at the start and end of the protocol, values of lipid, glucose, reactive protein C, alanine aminotransferase, and glycosylated hemoglobin profiles will be determined through spectrophotometric methods. The levels of expression of five miARN involved in regulating genes related to glucose metabolism (miR-320, miR-33a/b, miR-145, miR-335, and miR-124a) will be determined also by means of PCR amplification techniques. Statistical analyses will be based on two-way ANOVA, with a Dunnet's test procedure to find significance in measurements; significance will be set at p ≤ 0.05.

NCT ID: NCT02565654 Not yet recruiting - Clinical trials for Irritable Bowel Syndrome

Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome

Start date: October 2015
Phase: N/A
Study type: Observational

Irritable bowel syndrome (IBS) is a common disease and the pathogenesis of this disease includes central and peripheral mechanisms. In recent years, there were many studies suggesting that microbiota in the intestine may play an important role in the IBS.What's more, small intestinal bacterial overgrowth (SIBO) may be an important pathogenic factor for IBS and the use of antibiotics may be beneficial. Therefore, the investigators intend to explore the efficacy of rifaximin for IBS-D in Chinese population.

NCT ID: NCT02551367 Not yet recruiting - Clinical trials for Polycystic Ovary Syndrome

Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS )

LVCCFOROI
Start date: October 2015
Phase: Phase 2
Study type: Interventional

110 infertile women diagnosed as polycystic ovary syndrome (PCOS) at the age group of 20-35 distributed randomly : - 55 women will receive letrozole 2.5mg twice daily orally from the 2nd day to the 6thday of the cycle for three successive cycles. - 55 women will receive clomiphene citrate 50 mg twice daily orally from the 2nd day to the 6thday of the cycle for three successive cycles. Patients will be subjected to: Complete history taking: 1. Details about name, age 2. Menstrual history with determination of menarche 3. Amenorrhea or oligomenorrhea , Regularity of the cycle 4. History of endocrine disease. 5. History of previous operations. - Physical examination: - General examination: With special concern to: --Acne. --Hirsutism . --Weight. --Height --BMI was determined : Wt. in kg ـــــــــــــــــــ = ) Height in m)2 - Abdominal examination : - for scar of previous pelvic or abdominal operations . - Pelvic examination : - vaginal examination for enlarged cystic ovaries. - ultrasound for diagnosis of pcos. PARAMETERS: (1) rate of ovulation (primary parameter). (2) serum progesterone level on day 21. (3) number of mature follicles produced per cycle. (4) mean endometrial thickness. (6) chemical pregnancy. (7) ongoing pregnancy

NCT ID: NCT02510586 Not yet recruiting - Moyamoya Disease Clinical Trials

Sevoflurane and Hyperperfusion Syndrome

Start date: August 2015
Phase: N/A
Study type: Interventional

The aim of the present study is to evaluate the effect of sevoflurane postconditioning on the incidence of postoperative hyperperfusion syndrome following revascularization surgery in moyamoya patients.

NCT ID: NCT02497820 Not yet recruiting - Clinical trials for Lynch Syndrome I (Site-specific Colonic Cancer)

Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers

CaPP3 Israel
Start date: September 2016
Phase: Phase 3
Study type: Interventional

A randomised double blind dose non-inferiority trial of a daily dose of 600mg versus 300mg versus 100mg of enteric coated aspirin as a cancer preventive in carriers of a germline pathological mismatch repair gene defect, Lynch Syndrome. Project 3 in the Cancer Prevention Programme (CaPP3).

NCT ID: NCT02402049 Not yet recruiting - Clinical trials for Premenstrual Syndrome-PMS

Homeopathic Treatment of Premenstrual Syndrome

Start date: March 2015
Phase: Phase 3
Study type: Interventional

The proposed study will focus on premenstrual syndrome (PMS) symptom alleviation for women diagnosed as suffering from the syndrome with the DRSP questionnaire. The women will be treated with Homeopatic remedies. The improvement of PMS symptoms will be evaluated using the Daily Record of Severity of Problems questionnaire (DRSP). The questionnaire will be completed daily by women for 2 months prior to receiving the treatment and for 3 months following treatment with a single dose of the homeopathy treatment.

NCT ID: NCT02392520 Not yet recruiting - Clinical trials for Ovarian Hyperstimulation Syndrome

Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)

Start date: May 2015
Phase: N/A
Study type: Interventional

The study aims to compare the novel method of GnRH antagonist administration in the luteal phase versus conventional treatment in IVF patients who develop severe early ovarian hyperstimulation syndrome and have all their embryos cryopreserved.

NCT ID: NCT02381587 Not yet recruiting - Clinical trials for Primary Sjogren Syndrome With Multisystem Involvement

the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients

HAS
Start date: April 2015
Phase: N/A
Study type: Observational

sjogren syndrome is an autoimmune disease that mainly affects the Salivary glands and Lacrimal gland In addition to the effects of this disease is characterized by overall systemic Muskals injury, pulmonary disease, peripheral neuropathy and vasculitis. In addition recent studies have shown that patients are at increased risk of the disease up to 2 cardiac events and stroke events Hydroxychloroquine is an RHEUMATIC DISEASE PROCESS SUPPRESSANTS-ANTIMALARIALS used to treat anti-inflammatory rheumatic diseases in many first-line treatment is sjogren syndrome. A recent study of the treatment in Hydroxychloroquine effect on lipid profile sjogren syndrome patients showed a reduction in total cholesterol levels and increase in HDL. Further studies of the impact made Hydroxychloroquine systemic lupus patients erythematosus (SLE) showed in Atherosclerosis and morbidity and mortality reduction in cardiovascular. Studies of patients with rheumatoid arthritis (RA) demonstrated reduced risk of developing diabetes and improved lipid profile Research Goals valuate The effect of HCQ treatment in cardiovascular patients with primary sjogren syndrome